Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Gene context drift identifies drug targets to mitigate cancer treatment resistance

Cancer Cell(2025)10.1016/j.ccell.2025.06.005Source: DataRank Database

Gene context drift identifies drug targets to mitigate cancer treatment resistance is a research paper published in Cancer Cell (2025). On theSindex it has a DataRank of 0.208. It has been cited 3 times.

N/A

0.208DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 3.19)OA: hybridTopics (48)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.208

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (34)

Sabrina Terranova,Erica Nathan,Linda P. Hu,Jessica T. Taylor,Katherine E. Masih ORCID

Live enrichment

PubMed:40578362 OpenAlex:https://openalex.org/W4411674057

UK Dementia Research Institute

Grant: UKDRI-2006

Alex's Lemonade Stand Foundation for Childhood Cancer

Grant: 1260475

National Institutes of Health

Grant: R01 NS088566

NIGMS NIH HHS

Grant: T32 GM144273

Brain Tumor Charity

Glenn Foundation for Medical Research

AstraZeneca

Cancer Research UK

Medical Research Council

FWCI

3.19

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.ccell.2025.06.005

publisherhttps://doi.org/10.1016/j.ccell.2025.06.005

publisherhttps://api.elsevier.com/content/article/PII:S1535610825002557?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610825002557?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40578362

Fields of Study

Cancer Genomics and DiagnosticsEpigenetics and DNA MethylationSingle-cell and spatial transcriptomicsHumansAnimalsDrug Resistance, NeoplasmMiceTriple Negative Breast NeoplasmsGene Expression Regulation, NeoplasticSingle-Cell AnalysisNeoplasmsMedulloblastomaFemaleGene Expression ProfilingGene Regulatory Networks

MeSH Terms

AnimalsFemaleHumansMedulloblastomaNeoplasmsGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmGene Expression ProfilingMiceGene Regulatory NetworksSingle-Cell AnalysisTriple Negative Breast Neoplasms

Keywords

Context (archaeology)Cancer drugsDrug resistanceBiologyGeneCancerCancer researchCancer cellDrugGeneticsComputational biologyPharmacologyDNA repairRadiationCombination therapyChoroid PlexusMachine LearningTreatment ResistanceTriple-negative Breast CancerChoroid Plexus CarcinomaGraph Networks

Sustainable Development Goals

SDG 0: Good health and well-being